Board of Directors

Robert L. Zerbe, M.D., CEO, QuatRx Pharmaceuticals Company

Robert L. Zerbe, M.D. has served as a member of our board of directors since November 2005. In December 2000, Dr. Zerbe founded and has since served as the chief executive officer of QuatRx Pharmaceuticals Company, a biopharmaceutical company. Dr. Zerbe has extensive experience in regulatory affairs and global clinical development at Eli Lilly (U.S. & U.K.), where he held a variety of research and development positions, including managing director, Lilly Research Center U.K., and vice president of clinical investigation and regulatory affairs. He joined Parke-Davis in 1993, becoming senior vice president of worldwide clinical research and development, during which he oversaw the successful clinical development programs for Lipitor, Neurontin and other key products. Dr. Zerbe earned his medical degree at Indiana University and did post-graduate training in internal medicine, endocrinology and neuroendocrinology at Indiana University and the National Institutes of Mental Health.